Latest News and Press Releases

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a...

Remibrutinib, a highly selective oral BTKi, has potential to be first targeted therapy approved for CSU in Europe Improvements with remibrutinib observed as early as Week 1 in REMIX 1 & 2, with...

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (“Kratos”) (NASDAQ: KTOS), a Technology, Hardware, Products, System and Software Company addressing the...

Aura Announces Q4 2025 and 2025 Financial and Operational Results

SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (“Kratos”) (NASDAQ: KTOS), a Technology, Hardware, Products, System and Software Company addressing the...

2025 Results Press release - Paris, February 26th, 2026 Strong profitability improvement and record free cash-flow generation,reflecting the relevance of the Group’s strategy 2025 Sales at €1,217m,...

VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) ("Foremost" or the "Company") is pleased to report results from its targeted...

All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year...

Paris, 26 February 2026 PRESS RELEASE Very robust 2025 results and free cash flow at a record level Group sales, as published, stable at €56.9bn, including exchange rate effects of around -€580m in...

Ivry-sur-Seine, February 25, 2026, 5:45 p.m. CET LFL REVENUE1 UP +0.7% DRIVEN BY SERVICESGROSS MARGIN RATE INCREASE (+50 bps)2025 CURRENT OPERATING MARGIN OF 2.0%2PROPOSED DIVIDEND OF €1.00 PER...